Mal J Nutr 21(1): 67 - 73, 2015

Doxorubicin Cytotoxicity in Combination with Soy Isoflavone Daidzein on MCF-7 Breast Cancer Cells
Farjadian S1, Khajoei Nejad L2, Fazeli M2, Askari Firouzjaei H3 & Zaeri S4

ABSTRACT

Introduction: Combination chemotherapy regimens offer a promising approach to the prevention of recurrence, metastasis and drug resistance during breast cancer management. Combined tumor therapy using natural substances is highly suggested. Daidzein is one of the major isoflavones in soy beans with anti-tumor activity but its effect in combination with common chemotherapeutic agents is still unclear. This study was designed to investigate whether daidzein increases the antitumor activity of doxorubicin against MCF-7 human breast cancer cells.
Methods: The cytotoxic activity of doxorubicin, daidzein and a combination of the two drugs was determined at different concentrations using LDH release assay. The average values of each experiment were adjusted to the values determined from untreated controls and 50% inhibitory concentration (IC.) value for each drug was calculated by CompuSyn. In vitro interaction was also calculated using different combinations of doxorubicin and daidzein. Combination indices (CI) were calculated and combination index plot was constructed using the same software.
Results: Analysis of the dose-effect curve showed that the treatment of MCF-7 cells with doxorubicin or daidzein for 24 h led to 50% cytotoxicity at 5.4 nM and 146.5 respectively.
Conclusion: The Combination index plot showed CI >1 for all combinations used in this study which indicates antagonistic interactions between daidzein and doxorubicin. This study results have implications for patients with breast cancer under treatment with doxorubicin if they are taking daidzein as a dietary supplement.

Keywords: Breast cancer, daidzein, doxorubicin, MCF-7, soy isoflavone

Download full article

March 1995, Vol1 No.1
September 1995, Vol1 No.2
March 1996, Vol2 No.1
September 1996, Vol2 No.2
March 1997, Vol3 No.1
September 1997, Vol3 No.2
December 1998, Vol4 No.1&2
December 1999, Vol5 No.1&2
March 2000, Vol6 No.1
September 2000, Vol6 No.2
Mar/Sept 2001, Vol7 No.1&2
March 2002, Vol8, No.1
September 2002, Vol8, No.2
March 2003, Vol9 No.1
September 2003, Vol9 No.2
March 2004, Vol10 No.1
September 2004, Vol10 No. 2
2005, Vol 11 No.1
2005, Vo l11 No.2
2006, Vol 12 No.1
2006, Vol 12 No.2
2007, Vol 13 No.1
2007, Vol 13 No.2
March 2008, Vol 14 No.1
2008, Vol 14 No.2
2009, Vol 15 No.1
2009, Vol 15 No.2
2010, Vol 16(1)

2010, Vol 16(2)

2010, Vol 16(3)

2011, Vol 17(1)

2011, Vol 17(2)

2011, Vol 17(3)

2012, Vol 18(1)

2012, Vol 18(2)

2012, Vol 18(3)

2013, Vol 19(1)

2013, Vol 19(2)

2013, Vol 19(3)

2014, Vol 20(1)

2014, Vol 20(2)

2014, Vol 20(3)

2015, Vol 21(1)

2015, Vol 21(2)

2015, Vol 21(3)

2016, Vol 22(1)

2016, Vol 22(2)

2016, Vol 22 Supplement

2016, Vol 22(3)

2017, Vol 23(1)

2017, Vol 23(2)